Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer breaks ground on new manufacturing plant in Saudi Arabia
Pfizer’s new pharmaceutical manufacturing plant will be built at the Industrial Valley, King Abdullah Economic City, on the west coast of the Red Sea, north of Jeddah. The
Pfizer’s new pharmaceutical manufacturing plant will be built at the Industrial Valley, King Abdullah Economic City, on the west coast of the Red Sea, north of Jeddah. The
The approval of the spray followed the validation of convincing pre-clinical and clinical data on the safety and effectiveness of the drug. It is said to reduce the
The registration, which was filed under InB: Hauser Pharmaceutical Services, will now allow the firm to immediately manufacture schedule II-V compounds. With the new DEA registration status CHO
ClinStar provides Phase I-IV clinical research trials and clinical development services to a wide range of pharmaceutical and biotechnology companies in the Russian Federation, Ukraine, Belarus and the
Taiho is seeking approval of TAS-102 for the indication of unresectable, advanced, recurrent colorectal cancer. The application is based on the results of a Phase II clinical trial
Both the firms, which have been working together since 2007, have created a lean supply chain, prior to which the pharmaceutical firm’s manufacturing plants operated independently and managed
In February 2012, IDT and SGI began to co-manufacture and commercialize small synthetic gene products up to 5 kb, while IDT has also launched its gBlocks Gene Fragments
Created using patent-pending Cunermuspir complex, the new supplement supports optimum neuromuscular health and provides energy. Cunermuspir Complex helps to improve the body’s ability to absorb copper to support
Using the company’s novel and proprietary monomeric Fc fusion technology, clotting factor rFIXFc provides long-lasting protection from bleeding and reduces the treatment burden associated with hemophilia B. The
The small molecule therapeutic, which has dual mode of action including anti-catabolic and pro-anabolic activity, is indicated for the treatment of cancer cachexia, a wasting syndrome characterized by